Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Rohto Pharmaceutical, a leading Japanese pharmaceutical company, is dedicated to global health and well-being. The company develops and distributes innovative products in areas such as eye drops, skincare, and digestive medicine. With a focus on research and quality, Rohto Pharmaceutical offers high-quality solutions for consumers worldwide, driving advancements in health and personal care.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Rohto Pharmaceutical is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Rohto Pharmaceutical last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 47.14 JPY.
Across its last 4 earnings reports, Rohto Pharmaceutical stock moved by ±0.8% on average the following day. The largest reaction was +1.7% on 02/12/2025; 4 of 4 reactions were positive.
Rohto Pharmaceutical has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.